<DOC>
	<DOCNO>NCT01557842</DOCNO>
	<brief_summary>The purpose study determine early ablation ( i.e. , ablation ventricular tachycardia patient infrequent VT episode ) effective medical therapy alone treatment ischemic ventricular tachycardia patient Implantable Cardioverter Defibrillators ( ICDs ) continue episode ventricular tachycardia despite drug therapy .</brief_summary>
	<brief_title>Early Ablation Therapy Treatment Ischemic Ventricular Tachycardia Patients With Implantable Cardioverter Defibrillators</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<mesh_term>Anti-Arrhythmia Agents</mesh_term>
	<criteria>1 . Subject must drug refractory Class IIV AADs ( i.e. , VT episodes despite drug therapy ) . Subject must least one AAD time enrollment 2 . Qualifying episode must sustain , monomorphic Ventricular Tachycardia post myocardial infarction 3 . ICD implant 4 . 1 3 sustained monomorphic VT episodes require appropriate therapy within previous six ( 6 ) month determine investigator 5 . History myocardial infarction document development pathological Q wave without symptom , image evidence region loss viable myocardium thin fails contract absence nonischemic cause , pathological finding heal heal myocardial infarction 6 . 18 year old 7 . Able willing comply pre followup test requirement 8 . Signed Informed Consent Form 1 . Age &lt; 18 year 2 . Documented intraatrial ventricular thrombus abnormality preablation echocardiogram 3 . Patients Incessant Ventricular Tachycardia ( continuous sustain VTs recur promptly despite repeat intervention termination several ( ≥ 3 ) hour ) 4 . Contraindication anticoagulation 5 . NYHA class IV 6 . Left ventricular assist device ( LVADs ) circulatory assist device 7 . Stroke confirm plasma ddimer level acute myocardial infarction document electrocardiogram cardiac imaging within past three ( 3 ) month . ( Note small cardiac enzyme release result VT/shocks/etc . consider myocardial infarction . ) 8 . Patients active ischemia eligible revascularization 9 . Patients idiopathic Ventricular Tachycardia Ventricular Tachycardia nonischemic cause ( nonischemic cardiomyopathy ) 10 . Other disease process likely limit survival le 12 month 11 . Serum creatinine ≥ 2.5mg/dl 12 . Thrombocytopenia coagulopathy 13 . Prior ablation Ventricular Tachycardia 14 . Women pregnant ( evidenced pregnancy test premenopausal ) 15 . Enrollment study evaluate investigational device drug 16 . Unable unwilling comply protocol requirement 17 . Exclusively Polymorphic Ventricular Tachycardia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Ischemic</keyword>
	<keyword>Ventricular Tachycardia</keyword>
	<keyword>Implantable Cardioverter Defibrillators</keyword>
	<keyword>Antiarrhythmic Drug Therapy</keyword>
	<keyword>Ablation</keyword>
	<keyword>Electrophysiology</keyword>
</DOC>